Pharmacokinetics of Geniposide by Monoclonal Antibody-Based icELISA in Mice after Oral Administration of Huanglian-Jiedu-Tang
-
- Qu Hui-Hua
- Center of Scientific Experiment, Beijing University of Chinese Medicine
-
- Sun Ye
- School of Basic Medical Sciences, Beijing University of Chinese Medicine
-
- Wu Ting-Ting
- School of Basic Medical Sciences, Beijing University of Chinese Medicine
-
- Zhang Gui-Liang
- School of Basic Medical Sciences, Beijing University of Chinese Medicine
-
- Cheng Jin-Jun
- School of Basic Medical Sciences, Beijing University of Chinese Medicine
-
- Wang Xue-Qian
- School of Basic Medical Sciences, Beijing University of Chinese Medicine
-
- Feng Hui-Bin
- School of Basic Medical Sciences, Beijing University of Chinese Medicine
-
- Zhao Yan
- School of Basic Medical Sciences, Beijing University of Chinese Medicine
-
- Wang Qing-Guo
- School of Basic Medical Sciences, Beijing University of Chinese Medicine
この論文をさがす
抄録
Geniposide, Geniposide, the main active component in extracts of Gardenia jasminoides ELLIS., is one of the main components of Huanglian-Jiedu-Tang (HJT). This study aimed to validate an indirect competitive enzyme-linked immunosorbent assay (icELISA) based on monoclonal antibodies (mAb) against geniposide (anti-geniposide mAb), which was developed by our lab, and apply the assay to study the pharmacokinetics of geniposide in HJT in mice. Blood samples were drawn from mice at predetermined time points after oral administration of HJT in three dosages. A linear correlation was obtained for geniposide concentrations in the range from 1.17 to 37.50 µg/mL. The intra-day and inter-day precision values of the icELISA method were well within the recommended range (≤10%). The recovery rates ranged from 99.74 to 102.40%. Stability studies showed that geniposide sample solutions were intact for 12 h. The Tmax and mean residence time (MRT) of geniposide of the three groups were consistent with previous data. The results suggest that a reliable and effective method was established and could be applied to the study of the pharmacokinetics of geniposide in HJT.
収録刊行物
-
- Biological & Pharmaceutical Bulletin
-
Biological & Pharmaceutical Bulletin 37 (9), 1525-1533, 2014
公益社団法人 日本薬学会
- Tweet
キーワード
詳細情報 詳細情報について
-
- CRID
- 1390001204633759104
-
- NII論文ID
- 130004684794
-
- NII書誌ID
- AA10885497
-
- COI
- 1:STN:280:DC%2BC2M%2FmvFKgsw%3D%3D
-
- ISSN
- 13475215
- 09186158
-
- NDL書誌ID
- 025736995
-
- PubMed
- 25177035
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- NDL
- Crossref
- PubMed
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可